The Current Study Aimed to Evaluate the Therapeutic Features and Complications of Liver Hydatid Cyst in Patients Who Underwent Surgery for CE in Fars Province, Southern Iran.

Sponsor
Shiraz University of Medical Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT04363151
Collaborator
(none)
293
1
179.3
1.6

Study Details

Study Description

Brief Summary

The current study aimed to evaluate the therapeutic features and complications of liver hydatid cyst in patients who underwent surgery for CE in Fars province, southern Iran.

A total of 293 patients who underwent surgery for liver hydatid cyst from 2004 to 2018 in Fars Province, southern Iran, were retrospectively evaluated. The clinical records of patients were reviewed and the demographic and clinical characteristics of each patient were assessed.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention.

Detailed Description

Fars province with the capital of Shiraz in one of the thirty-one provinces of Iran located in the southwest part of the country with a population of more than 4.6 million people of which 67.6% living in urban areas, 32.2% in rural areas and 0.3% live as nomad tribes. The average temperature of Fars province is 17.8 °C, ranging between 4.7 °C and 29.2 °C and the annual rainfall is 261mm. Animal farming and agriculture are of great importance as they are considered as two main economic bases of this province. This type of livelihood has facilitated the presence of some of the zoonotic diseases such as CE and toxocariasis and leishmaniasis.

Data Collection Hospital records of a total of 293 patients who underwent surgery for liver hydatid cyst from 2004 to 2018 in two major university-affiliated hospitals in Fars Province, southern Iran, were retrospectively evaluated. In all cases, the preliminary diagnosis of hydatid cyst has been confirmed by postoperative pathological findings. So, the inclusion criterion of operation with the diagnosis of CE was considered while reviewing the records.

Information such as age, sex, presenting signs and symptoms of hydatid cyst, number and the specific location of cystic structures, history of relapse, reoperation, characteristics of the cyst (calcification, puss discharge, multicystic, multiloculated, daughter cyst, rupture, inflammation, superimposed infection, and septation), early postoperative complications, diagnostic procedures such as ultrasound scanning, computed tomography, X-rays, pathology reports, lab data, operation information and, drug therapy were extracted from the hospital records of each patient. The surgical procedure used for the patients, radical or conservative, was noted.

Study Design

Study Type:
Observational
Actual Enrollment :
293 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Management of Liver Hydatid Cysts: A Retrospective Analysis of 293 Cases From Southern Iran
Actual Study Start Date :
Jan 15, 2004
Actual Primary Completion Date :
Dec 25, 2018
Actual Study Completion Date :
Dec 25, 2018

Arms and Interventions

Arm Intervention/Treatment
Hydatid cyst patients

patients who underwent surgery for liver hydatid cyst from 2004 to 2018 in two major university-affiliated hospitals in Fars Province, southern Iran

Other: No intervention.

Outcome Measures

Primary Outcome Measures

  1. Demographic Information as well as patients clinical data were extracted from the hospital records of each patient. [2004 to 2018]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Inclusion Criteria:

Having a surgery due to Hydatid cyst

Exclusion Criteria:

Surgeries other than hydatid cyst.

-

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shiraz University of Medical Sciences Shiraz Fars Iran, Islamic Republic of 7134845794

Sponsors and Collaborators

  • Shiraz University of Medical Sciences

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bahador Sarkari, Pronciple investigator, Shiraz University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT04363151
Other Study ID Numbers:
  • 94-01-01-9212
First Posted:
Apr 27, 2020
Last Update Posted:
Apr 28, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bahador Sarkari, Pronciple investigator, Shiraz University of Medical Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 28, 2020